Publication:
Validation of the Spanish Activity Questionnaire in COPD (SAQ-COPD) in Patients with Chronic Obstructive Pulmonary Disease

dc.contributor.authorSoler-Cataluña, Juan José
dc.contributor.authorPuente Maestu, Luis
dc.contributor.authorRoman-Rodriguez, Miguel
dc.contributor.authorEsteban, Cristobal
dc.contributor.authorGea, Joaquín
dc.contributor.authorBernabeu Mora, Roberto
dc.contributor.authorPleguezuelos Cobo, Eulogio
dc.contributor.authorAncochea, Julio
dc.contributor.authorGarcía-Río, Francisco
dc.date.accessioned2024-10-04T13:58:08Z
dc.date.available2024-10-04T13:58:08Z
dc.date.issued2022
dc.description.abstractPurpose: The Spanish Activity Questionnaire in COPD (SAQ-COPD) is a short, simple physical activity (PA) measurement instrument for patients with chronic obstructive pulmonary disease (COPD). In this study, we analyzed its validity and sensitivity to change. Methods: Prospective scale validation study. An accelerometer (DynaPort MoveMonitor®) and the Yale Physical Activity Survey (YPAS) were used as reference standards. The analyses examined the criterion validity (Spearman correlations), internal consistency (Cronbach's alpha), factorial structure, test-retest reliability (intraclass correlation coefficient, ICC), sensitivity to change and receiver operating characteristic (ROC) curve to classify patients with low PA. Results: A total of 300 patients diagnosed with COPD were analyzed (73% males, mean age 66 ± 8 years, 40.3% with severe airflow limitation). Cronbach's alpha was 0.60 and Spearman's correlations with accelerometer measurements of PA [number of steps, metabolic equivalents (MET), physical activity level (PAL)] and YPAS ranged from 0.37 to 0.53 (all p < 0.001). ICC was 0.69 (95% CI 0.61-0.74) and the area under the ROC curve to identify low PA was 0.65 (95% confidence interval: 0.58-0.73). Significant variations in SAQ-COPD scores were found between groups defined by YPAS for change. Conclusion: The SAQ-COPD questionnaire is a valid instrument for classifying PA in patients with COPD. Correlations with other instruments provide criterion validity and also demonstrate good sensitivity to change.en
dc.description.sponsorshipThis study was funded by AstraZeneca Farmacéutica Spain, S.A.es_ES
dc.format.page2835es_ES
dc.format.volume17es_ES
dc.identifier.citationSoler-Cataluña JJ, Puente Maestu L, Román Rodríguez M, Esteban C, Gea J, Bernabeu Mora R, et al. Validation of the Spanish Activity Questionnaire in COPD (SAQ-COPD) in Patients with Chronic Obstructive Pulmonary Disease. Int J Chron Obstruct Pulmon Dis. 2022 Nov;Volume 17:2835-46en
dc.identifier.doi10.2147/COPD.S381427
dc.identifier.e-issn1178-2005es_ES
dc.identifier.journalInternational journal of chronic obstructive pulmonary diseasees_ES
dc.identifier.otherhttp://hdl.handle.net/20.500.13003/18649
dc.identifier.pubmedID36381995es_ES
dc.identifier.puiL2018445668
dc.identifier.scopus2-s2.0-85141348954
dc.identifier.urihttps://hdl.handle.net/20.500.12105/23557
dc.identifier.wos885320500001
dc.language.isoengen
dc.publisherDove Medical Press
dc.relation.publisherversionhttps://doi.org/10.2147/COPD.S381427en
dc.rights.accessRightsopen accessen
dc.rights.licenseAtribution-NonComercial 4.0 International*
dc.rights.urihttp://creativecommons.org/licenses/by-nc/4.0/*
dc.subject.decsEnfermedad Pulmonar Obstructiva Crónica*
dc.subject.decsHumanos*
dc.subject.decsPersona de Mediana Edad*
dc.subject.decsReproducibilidad de los Resultados*
dc.subject.decsEstudios Prospectivos*
dc.subject.decsAsma*
dc.subject.decsAnciano*
dc.subject.decsFemenino*
dc.subject.decsEncuestas y Cuestionarios*
dc.subject.decsPsicometría*
dc.subject.decsMasculino*
dc.subject.meshAsthma*
dc.subject.meshMale*
dc.subject.meshAged*
dc.subject.meshProspective Studies*
dc.subject.meshFemale*
dc.subject.meshPulmonary Disease, Chronic Obstructive*
dc.subject.meshHumans*
dc.subject.meshMiddle Aged*
dc.subject.meshPsychometrics*
dc.subject.meshReproducibility of Results*
dc.subject.meshSurveys and Questionnaires*
dc.titleValidation of the Spanish Activity Questionnaire in COPD (SAQ-COPD) in Patients with Chronic Obstructive Pulmonary Diseaseen
dc.typeresearch articleen
dspace.entity.typePublication
relation.isPublisherOfPublicationba22643b-836b-4738-8dc3-444eb4bd4ec4
relation.isPublisherOfPublication.latestForDiscoveryba22643b-836b-4738-8dc3-444eb4bd4ec4

Files